The present invention relates to novel crystalline forms of Epirubicin hydrochloride "SBL-1", "SBL-2" and "SBL-3" in particular "SBL-3", which is useful as an anti-cancer chemotherapeutic drug. The present invention also provides process for preparing novel crystalline forms of Epirubicin hydrochloride "SBL-1", "SBL...

The present invention relates to a process for the purification of lovastatin that reduces the level of unknown impurities to below 0.10%. The present invention also discloses a process that is short  less time taking  and industrially viable. The invention also relates to the use of purified lovastatin obtained by ...

A process for the preparation of E-3- [2-(7-chloro-2-quinolinyl)etheny 1] benzaldehyde, a key intermediate for synthesizing montelukast acid and its salt This  invention  relates  to  a  process  for  the  preparation  of  3-[2-(7-chloro-2-quinolinyl)ethenyl]benzaldehyde which comprises of; a) reacting 7-chloroq...

The present invention relates to an improved scalable and economical process for the preparation of substantially pure Idarubicin hydrochloride, a useful anti-cancer chemotherapeutic drug. In particular, this invention relates to a process wherein Idarubicin hydrochloride is obtained in a substantially pure form and...

The present invention relates to a novel process for preparing polymorphic forms of imatinib mesylate. In particular, the invention relates to preparation of a and p forms of imatinib mesylate. More specifically, the present invention relates to preparation of both a and p forms of 4-[(4-methylpiperazin-l-yl)meth...